U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Refractory Glioma

MedGen UID:
1633847
•Concept ID:
C4687707
•
Neoplastic Process

Definition

Glioma that does not respond to treatment. [from NCI]

Professional guidelines

PubMed

Molecular stratifications, biomarker candidates and new therapeutic options in current medulloblastoma treatment approaches.
Menyhárt O, Győrffy B
Cancer Metastasis Rev 2020 Mar;39(1):211-233. doi: 10.1007/s10555-020-09854-1. PMID: 31970590Free PMC Article
Targeting the Warburg effect for cancer treatment: Ketogenic diets for management of glioma.
Poff A, Koutnik AP, Egan KM, Sahebjam S, D'Agostino D, Kumar NB
Semin Cancer Biol 2019 Jun;56:135-148. Epub 2017 Dec 30 doi: 10.1016/j.semcancer.2017.12.011. PMID: 29294371Free PMC Article
EANO guidelines for the diagnosis and treatment of meningiomas.
Goldbrunner R, Minniti G, Preusser M, Jenkinson MD, Sallabanda K, Houdart E, von Deimling A, Stavrinou P, Lefranc F, Lund-Johansen M, Moyal EC, Brandsma D, Henriksson R, Soffietti R, Weller M
Lancet Oncol 2016 Sep;17(9):e383-91. Epub 2016 Aug 30 doi: 10.1016/S1470-2045(16)30321-7. PMID: 27599143

Recent clinical studies

Etiology

A phase 2 study of trametinib for patients with pediatric glioma or plexiform neurofibroma with refractory tumor and activation of the MAPK/ERK pathway: TRAM-01.
Perreault S, Larouche V, Tabori U, Hawkin C, Lippé S, Ellezam B, Décarie JC, Théoret Y, Métras MÉ, Sultan S, Cantin É, Routhier MÈ, Caru M, Legault G, Bouffet É, Lafay-Cousin L, Hukin J, Erker C, Jabado N
BMC Cancer 2019 Dec 27;19(1):1250. doi: 10.1186/s12885-019-6442-2. PMID: 31881853Free PMC Article
miR‑342 inhibits glioma cell proliferation by targeting GPRC5A.
Wang J, Yang Y, Cao Y, Tang X
Mol Med Rep 2019 Jul;20(1):252-260. Epub 2019 May 15 doi: 10.3892/mmr.2019.10242. PMID: 31115523Free PMC Article
An adenovirus encoding proapoptotic Bax synergistically radiosensitizes malignant glioma.
Arafat WO, Buchsbaum DJ, Gómez-Navarro J, Tawil SA, Olsen C, Xiang J, El-Akad H, Salama AM, Badib AO, Stackhouse MA, Curiel DT
Int J Radiat Oncol Biol Phys 2003 Mar 15;55(4):1037-50. doi: 10.1016/s0360-3016(02)04488-7. PMID: 12605984

Therapy

A Phase 1/2A trial of idroxioleic acid: first-in-class sphingolipid regulator and glioma cell autophagy inducer with antitumor activity in refractory glioma.
Lopez J, Lai-Kwon J, Molife R, Welsh L, Tunariu N, Roda D, Fernández-García P, Lladó V, McNicholl AG, Rosselló CA, Taylor RJ, Azaro A, Rodón J, Sludden J, Veal GJ, Plummer R, Urruticoechea A, Lahuerta A, Mujika K, Escribá PV
Br J Cancer 2023 Sep;129(5):811-818. Epub 2023 Jul 24 doi: 10.1038/s41416-023-02356-1. PMID: 37488446Free PMC Article
A phase 2 study of trametinib for patients with pediatric glioma or plexiform neurofibroma with refractory tumor and activation of the MAPK/ERK pathway: TRAM-01.
Perreault S, Larouche V, Tabori U, Hawkin C, Lippé S, Ellezam B, Décarie JC, Théoret Y, Métras MÉ, Sultan S, Cantin É, Routhier MÈ, Caru M, Legault G, Bouffet É, Lafay-Cousin L, Hukin J, Erker C, Jabado N
BMC Cancer 2019 Dec 27;19(1):1250. doi: 10.1186/s12885-019-6442-2. PMID: 31881853Free PMC Article
The synergistic therapeutic effect of temozolomide and hyperbaric oxygen on glioma U251 cell lines is accompanied by alterations in vascular endothelial growth factor and multidrug resistance-associated protein-1 levels.
Lu XY, Cao K, Li QY, Yuan ZC, Lu PS
J Int Med Res 2012;40(3):995-1004. doi: 10.1177/147323001204000318. PMID: 22906272
An adenovirus encoding proapoptotic Bax synergistically radiosensitizes malignant glioma.
Arafat WO, Buchsbaum DJ, Gómez-Navarro J, Tawil SA, Olsen C, Xiang J, El-Akad H, Salama AM, Badib AO, Stackhouse MA, Curiel DT
Int J Radiat Oncol Biol Phys 2003 Mar 15;55(4):1037-50. doi: 10.1016/s0360-3016(02)04488-7. PMID: 12605984

Prognosis

miR‑342 inhibits glioma cell proliferation by targeting GPRC5A.
Wang J, Yang Y, Cao Y, Tang X
Mol Med Rep 2019 Jul;20(1):252-260. Epub 2019 May 15 doi: 10.3892/mmr.2019.10242. PMID: 31115523Free PMC Article

Clinical prediction guides

A phase 2 study of trametinib for patients with pediatric glioma or plexiform neurofibroma with refractory tumor and activation of the MAPK/ERK pathway: TRAM-01.
Perreault S, Larouche V, Tabori U, Hawkin C, Lippé S, Ellezam B, Décarie JC, Théoret Y, Métras MÉ, Sultan S, Cantin É, Routhier MÈ, Caru M, Legault G, Bouffet É, Lafay-Cousin L, Hukin J, Erker C, Jabado N
BMC Cancer 2019 Dec 27;19(1):1250. doi: 10.1186/s12885-019-6442-2. PMID: 31881853Free PMC Article

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...